17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
California Governor Gavin Newsom has signed legislation that prohibits “no rehire” clauses in sett...
Read More >
A new Oregon law limits employers’ use of nondisclosure or nondisparagement agreements with their e...
Read More >
A look at some of the most well-read articles on employer liability issues published on JD Supra dur...
Read More >
Risk allocation between parties is a key consideration in the negotiation of merger and acquisition ...
Read More >
Our Unclaimed Property Group examines the recently enacted SECURE Act and the significant changes th...
Read More >
On September 24, 2019, the United States Department of Labor issued a new rule revising the salary t...
Read More >